Curran Terrie: insider trades.
Curran Terrie reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($984K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Curran Terrie
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-27 | Arcutis Biotherapeutics, Inc. | M | 27,052 | $8.63 | 50,578 | Form 4 |
| 2026-08-27 | Arcutis Biotherapeutics, Inc. | S | 11,148 | $25.03 | 23,526 | Form 4 |
| 2026-08-27 | Arcutis Biotherapeutics, Inc. | M | 11,148 | $7.51 | 34,674 | Form 4 |
| 2026-08-27 | Arcutis Biotherapeutics, Inc. | S | 27,052 | $25.03 | 23,526 | Form 4 |
| 2026-08-20 | Arcutis Biotherapeutics, Inc. | M | 1,072 | $7.51 | 24,598 | Form 4 |
| 2026-08-20 | Arcutis Biotherapeutics, Inc. | S | 1,072 | $26.04 | 23,526 | Form 4 |
Questions
What stock did Curran Terrie buy or sell?
Curran Terrie reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($984K), across 1 company.
Is Curran Terrie the same person as other filers with this name?
This page covers SEC CIK 1690298 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/curran-terrie-1690298.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.